AI

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026

biotech

Engineered immune cells trial to fight colorectal cancer approved

Jim Cornall - September 16, 2026

biotech

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

Jim Cornall - September 16, 2026

biotech

Lotus Neuro launches to deliver therapies across blood-brain barrier

Jim Cornall - September 15, 2026

AI

Disrupt.com to invest $100m into UAE AI startups

Jim Cornall - March 3, 2025

AI

Verint expands Global Innovation Center in India

Jim Cornall - February 21, 2025

AI

AI-driven breakthrough could accelerate bioeconomy

Jim Cornall - February 19, 2025

AI

iPRONICS raises €20m to advance optical networking

Jim Cornall - February 4, 2025

AI

VuNet raises $7m to boost global expansion and product innovation

Jim Cornall - January 29, 2025

AI

Pasqal and EDF address electric vehicle charging with quantum computing

Jim Cornall - January 23, 2025

AI

Perciv AI secures €2.5m to expand radar solutions

Jim Cornall - December 23, 2024

AI

NSAIT and ETH Zurich Entrepreneurs launch LogicStar AI

Jim Cornall - December 16, 2024

1...345...7 Page 4 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026 0

Revvity, Inc. has entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company specialising in human cell models and...

Engineered immune cells trial to fight colorectal cancer approved

biotech Jim Cornall - September 16, 2026 0

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

biotech Jim Cornall - September 16, 2026 0

Lotus Neuro launches to deliver therapies across blood-brain barrier

biotech Jim Cornall - September 15, 2026 0

Antibody targeting TSLP achieves positive results in asthma study

biotech Jim Cornall - September 15, 2026 0